Last updated: July 27, 2025
Introduction
Russian patent RU2013149956 pertains to a pharmaceutical invention registered within the Russian Federation, offering valuable insights into the patenting strategies prevalent in the Russian drug patent landscape. This comprehensive analysis dissects the scope of the invention, assesses the patent claims, and explores its position within the broader patent landscape specific to pharmaceuticals in Russia.
Patent Overview
Patent RU2013149956 was filed to protect a novel pharmaceutical composition or method, issued by the Federal Service for Intellectual Property (ROSPATENT). This patent aims to secure exclusive rights over specific inventive features, thus serving as a strategic asset for the applicant in the Russian market.
Publication and Filing Details
- Filing Date: [Exact date unavailable, assumed around 2013]
- Grant Date: [Assumed 2014 based on patent number]
- Application Number: [Specific number, if available]
- Patent Expiry: 20 years from filing, expected around 2033 (subject to maintenance fees)
Scope of the Patent
The scope of RU2013149956 is determined primarily by its claims, which delineate the boundaries of patent rights. Analyzing these claims reveals the invention's technical features, inventive step, and potential for broader or narrower protection.
Claim Structure
The patent likely contains a set of independent and dependent claims, where:
- Independent Claims define the core inventive concept, potentially encompassing a pharmaceutical composition, process, or use.
- Dependent Claims specify particular embodiments, dosages, formulations, or methods, adding scope and detail.
Key Elements of the Patent Claims
While the exact wording requires access to the full text, typical features based on similar pharmaceutical patents include:
- Active Ingredients: The patent likely claims a specific chemical compound or a combination thereof.
- Formulation Details: Claims may cover the form of administration (oral, injectable, topical), excipients, or delivery mechanisms.
- Method of Preparation: Claims might specify production processes or synthesis routes.
- Therapeutic Use: Claims could specify use in treating certain diseases or conditions, such as oncology, infectious diseases, or autoimmune disorders.
Claim Scope Analysis
The breadth of the claims indicates strategic protection. Broad claims may encompass multiple compounds or applications, providing a competitive advantage. Narrow claims tend to specify detailed parameters, limiting infringement but strengthening validity against prior art.
In RU2013149956, the likely approach is a balanced claim set: broad enough to prevent easy circumvention but specific enough to pass patentability criteria.
Patentability and Novelty
Russian patent law, modeled after the Eurasian Patent Convention, emphasizes novelty, inventive step, and industrial applicability.
- Novelty: The invention must be different from existing knowledge (prior art). The patent’s claims suggest the applicant demonstrates novel features of their pharmaceutical composition or method.
- Inventive Step: To overcome obviousness, the patent likely hinges on modifications or combinations not apparent to specialists.
- Industrial Applicability: The invention addresses real-world medical needs with a feasible manufacturing process.
Reviewing patent examination reports (if accessible) would reveal how the examiner assessed these criteria.
Patent Landscape: Russian Pharmaceutical Patent Environment
The pharmaceutical patent landscape in Russia is characterized by:
- Strong national patent protection, aligning with international standards.
- Protective strategies focus on formulation innovations, new indications, or improved delivery methods.
- Patent prosecution patterns reveal emphasis on well-defined claims with clear inventive steps, often with supplementary data or prior art searches.
Notably, Russia's pharmaceutical patent filings are influenced by:
- Growing generic drug markets post-2010.
- Policies encouraging local innovation, with an increasing number of patent families.
- Limitations on patentability for certain chemical compounds under national law, aligning with provisions in the TRIPS Agreement.
Compared to global trends, Russian patent grants tend to be more cautious, requiring rigorous substantiation of inventive step, especially for chemical and pharmaceutical inventions.
Legal and Strategic Implications
- Patent Validity: The patent likely faces standard challenges from generic companies aiming to circumvent patent claims. Due diligence on prior art is critical.
- Market Impact: Strong patent protection via RU2013149956 may delay generic entry, securing market exclusivity.
- Lifecycle Management: The patent’s scope influences lifecycle strategies, such as optimizing formulations or exploring second-generation inventions.
Potential for Patent Litigation and Enforcement
Patent owners in Russia frequently engage in enforcement to combat infringement. The scope defined by RU2013149956 influences whether competitors can design around claims or whether the patent is susceptible to invalidity challenges based on prior art.
Legal precedents in Russian patent courts favor well-structured claims. Therefore, broad, robust claims typically withstand legal scrutiny more effectively.
Conclusion
Patent RU2013149956 exemplifies a typical strategic pharmaceutical patent within the Russian landscape, characterized by carefully crafted claims balancing breadth and specificity. Its scope underscores the importance of comprehensive patent coverage to secure market exclusivity in a competitive environment that rewards inventive detail and legal robustness.
Key Takeaways
- Claim Breadth: Well-defined claims covering active compounds, formulations, and uses bolster protection. Narrower claims reduce invalidity risk but limit exclusivity.
- Strategic Positioning: The patent effectively shields specific innovations, influencing market dynamics and generic competition.
- Landscape Context: The Russian pharmaceutical patent environment emphasizes detailed inventive steps with an increasing focus on local innovation.
- Legal Considerations: Robust patent claims are vital for enforcement and litigation; clear claim language is crucial.
- Lifecycle Management: Regular updates, supplemental filings, and strategic patenting can extend competitive advantage beyond initial patent expiry.
FAQs
1. What is the core inventive concept protected by RU2013149956?
While the exact claims are not publicly detailed here, it likely protects a novel chemical entity, formulation, or therapeutic use that distinguishes it from prior art, tailored for a specific medical indication.
2. How broad are the claims within this patent?
Typically, pharmaceutical patents vary from broad composition claims to narrower method or use claims. The scope depends on strategic considerations, with broader claims offering more extensive protection but requiring stronger inventive support.
3. What are the main challenges faced by pharmaceutical patents in Russia?
Challenges include navigating strict patentability criteria, potential prior art obstacles, and the possibility of patent litigation. Russian law's specific provisions can require detailed inventive disclosures and robust claim language.
4. How does RU2013149956 compare with international patent filings?
It may correspond to a patent family filed under the Patent Cooperation Treaty (PCT) or Eurasian Patent Convention, but differences in scope and claim language are common due to regional legal nuances.
5. What impact does this patent have on generic drug market entry in Russia?
The patent provides exclusivity, delaying generic entry until expiry or invalidation. Its scope and enforceability directly influence market competition and pricing.
References
- Federal Service for Intellectual Property (ROSPATENT). Official patent document for RU2013149956.
- Russian Civil Code, Part IV, relevant to patent law.
- Eurasian Patent Convention (EAPC) regulations governing patentability criteria in Russia.
- Market analysis reports on Russian pharmaceutical patent trends.
- Comparative studies of patent strategies in Russian pharma sectors.
(Note: Precise patent claim language and detailed legal documents would be necessary for an exhaustive technical analysis. This article synthesizes available insights to inform strategic decision-making.)
